Activity

A Questionable 3-Year-Study Is Indicating That Common Diabetes Drug, Canagliflozin, With Brand Name, Invokana Could Also Reduce Risks Of Kidney Diseases And Cardiovascular Deaths In Folks With Type 2 Diabetes And Chronic Kidney Disease. But The Side Effects Of Invokana Could Be An Increased Risk Of Lower Limb Amputation And Bone Fracture.

Diabetes drug has heart and kidney benefits, researchers find – CNN

https://www.cnn.com/2019/04/14/health/canagliflozin-diabetes-kidney-drug-study/index.html

The risk of kidney failure and cardiovascular-related problems was lowered in patients with type 2 diabetes and kidney disease who took a daily dose of the drug canagliflozin as part of a new study. The drug itself, however, can increase the risk of limb amputation.